沃森生物
(300142)
| 流通市值：170.44亿 | | | 总市值：174.81亿 |
| 流通股本：15.59亿 | | | 总股本：15.99亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,504,949,235.39 | 3,763,574,789.88 | 3,622,884,537.8 | 3,334,740,632.67 |
| 应收票据及应收账款 | 2,378,511,079.19 | 2,409,639,849.34 | 2,715,126,017.46 | 2,988,546,278.59 |
| 应收账款 | 2,378,511,079.19 | 2,409,639,849.34 | 2,715,126,017.46 | 2,988,546,278.59 |
| 预付款项 | 19,672,200.5 | 10,294,958.74 | 10,303,478.6 | 14,866,974.91 |
| 其他应收款合计 | 82,300,812.41 | 78,108,165.66 | 81,024,154.4 | 84,378,897.87 |
| 应收股利 | - | - | - | 3,653,134.49 |
| 存货 | 711,018,444.19 | 752,587,288.16 | 908,621,580.08 | 1,007,043,101.35 |
| 一年内到期的非流动资产 | 3,906,000 | 2,604,000 | 2,604,000 | 2,604,000 |
| 其他流动资产 | 48,509,457.62 | 50,019,528.73 | 57,282,630.01 | 60,475,141.42 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 6,748,867,229.3 | 7,066,828,580.51 | 7,397,846,398.35 | 7,492,655,026.81 |
| 非流动资产: | | | | |
| 长期应收款 | 3,455,612.14 | 7,268,467.14 | 7,176,311.72 | 7,085,135.36 |
| 长期股权投资 | 15,096,296.9 | 15,232,596.48 | 15,177,309.47 | 15,103,801.16 |
| 其他权益工具投资 | 508,000,000 | 508,000,000 | 562,000,000 | 562,000,000 |
| 其他非流动金融资产 | 418,037,000 | 403,899,700 | 408,548,700 | 400,229,000 |
| 投资性房地产 | 24,224,981.63 | 24,661,407.59 | 26,772,317.56 | 27,149,203.66 |
| 固定资产 | 1,891,537,383.05 | 1,944,895,740.77 | 1,987,948,654.58 | 1,984,913,746.73 |
| 在建工程 | 2,139,986,596.14 | 2,113,826,293.63 | 1,990,327,681.23 | 1,972,285,643.14 |
| 使用权资产 | 15,735,736.69 | 19,782,809.91 | 26,450,822.92 | 32,549,708.76 |
| 无形资产 | 1,000,718,659.91 | 1,035,125,911.6 | 1,013,219,714.84 | 1,035,830,805.55 |
| 开发支出 | 462,575,226.18 | 450,917,536.17 | 443,248,350.18 | 426,209,454.86 |
| 商誉 | 33,657,636.81 | 33,657,636.81 | 33,657,636.81 | 33,657,636.81 |
| 长期待摊费用 | 58,473,619.27 | 62,943,637.16 | 63,932,635.48 | 68,203,554.2 |
| 递延所得税资产 | 100,808,466.78 | 104,556,557.74 | 96,278,782.68 | 97,865,533.48 |
| 其他非流动资产 | 942,909,606.65 | 932,715,033.74 | 931,123,687.07 | 930,514,455.21 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 7,615,216,822.15 | 7,657,483,328.74 | 7,605,862,604.54 | 7,593,597,678.92 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 14,364,084,051.45 | 14,724,311,909.25 | 15,003,709,002.89 | 15,086,252,705.73 |
| 流动负债: | | | | |
| 短期借款 | - | - | 220,157,222.24 | 240,175,000.01 |
| 应付票据及应付账款 | 1,660,990,786.53 | 1,567,776,768.12 | 1,504,662,922.87 | 1,576,131,759.84 |
| 其中：应付票据 | 19,828,693.42 | 20,063,410.44 | 16,215,468.34 | 8,241,007.87 |
| 应付账款 | 1,641,162,093.11 | 1,547,713,357.68 | 1,488,447,454.53 | 1,567,890,751.97 |
| 预收款项 | 3,963.34 | 6,412.88 | 2,917.46 | 5,366.99 |
| 合同负债 | 34,020,759.76 | 39,853,893.86 | 43,375,997.36 | 25,773,687.51 |
| 应付职工薪酬 | 28,944,749.08 | 72,603,419.61 | 29,816,532.1 | 25,652,071.24 |
| 应交税费 | 7,647,420.74 | 20,117,588.26 | 13,633,268.2 | 25,865,806.03 |
| 其他应付款合计 | 57,937,580.36 | 57,227,839.22 | 58,050,684.61 | 59,568,800.56 |
| 一年内到期的非流动负债 | 25,181,887.3 | 46,831,959.96 | 42,491,503.32 | 29,609,460.21 |
| 其他流动负债 | 246,512,058.97 | 565,584,420.08 | 477,764,687.31 | 566,491,589.9 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,061,239,206.08 | 2,370,002,301.99 | 2,389,955,735.47 | 2,549,273,542.29 |
| 非流动负债: | | | | |
| 长期借款 | 433,336,162.04 | 433,336,162.04 | 449,306,935.96 | 467,981,969.18 |
| 租赁负债 | 10,802,170.8 | 11,767,443.4 | 13,218,747.56 | 11,553,057.95 |
| 预计负债 | 47,308,772.25 | 66,999,124.01 | 73,027,140.57 | 65,986,952.88 |
| 递延收益 | 268,026,434 | 278,435,627.28 | 283,122,668.87 | 288,410,293.96 |
| 递延所得税负债 | 55,189,553.52 | 55,906,838.73 | 65,070,353 | 66,164,225.86 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 814,663,092.61 | 846,445,195.46 | 883,745,845.96 | 900,096,499.83 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,875,902,298.69 | 3,216,447,497.45 | 3,273,701,581.43 | 3,449,370,042.12 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,599,348,541 | 1,599,348,541 | 1,599,348,541 | 1,605,348,484 |
| 资本公积 | 4,548,884,512.54 | 4,548,884,512.54 | 4,548,884,512.54 | 4,829,301,212.8 |
| 减:库存股 | - | - | - | 286,416,643.26 |
| 其他综合收益 | 171,275,000 | 171,275,000 | 217,175,000 | 217,175,000 |
| 盈余公积 | 81,031,665.66 | 81,031,665.66 | 81,031,665.66 | 81,031,665.66 |
| 未分配利润 | 3,031,649,663.05 | 3,029,003,414.47 | 3,143,201,624.18 | 3,057,403,461.18 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 9,432,189,382.25 | 9,429,543,133.67 | 9,589,641,343.38 | 9,503,843,180.38 |
| 少数股东权益 | 2,055,992,370.51 | 2,078,321,278.13 | 2,140,366,078.08 | 2,133,039,483.23 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 11,488,181,752.76 | 11,507,864,411.8 | 11,730,007,421.46 | 11,636,882,663.61 |
| 负债和股东权益合计 | 14,364,084,051.45 | 14,724,311,909.25 | 15,003,709,002.89 | 15,086,252,705.73 |
| 公告日期 | 2025-04-26 | 2025-04-12 | 2024-10-26 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |